Bio-Rad Labs (BIO) Tops Q3 EPS by 53c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 -3.84%
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.91, $0.53 better than the analyst estimate of $0.38. Revenue for the quarter came in at $535 million versus the consensus estimate of $508 million.
GUIDANCE:
Bio-Rad Labs sees Q4 2017 revenue of $615-625 million, versus the consensus of $633 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
